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Abstract
The use of cannabis can impair cognitive function, especially short-term memory. A controversial question is whether long-
term cannabis use during the late-adolescence period can cause irreversible deficits in higher brain function that persist
after drug use stops. In order to examine the short- and long-term effects of chronic exposure to cannabinoids, rats were
administered chronic i.p. treatment with the CB1/CB2 receptor agonist WIN55,212-2 (WIN; 1.2 mg/kg) for two weeks during
the late adolescence period (post-natal days 45–60) and tested for behavioral and electrophysiological measures of
cognitive performance 24 hrs, 10 and 30 days after the last drug injection. The impairing effects of chronic WIN on short-
term memory in the water maze and the object recognition tasks as well as long-term potentiation (LTP) in the ventral
subiculum (vSub)-nucleus accumbens (NAc) pathway were temporary as they lasted only 24 h or 10 d after withdrawal.
However, chronic WIN significantly impaired hippocampal dependent short-term memory measured in the object location
task 24 hrs, 10, 30, and 75 days after the last drug injection. Our findings suggest that some forms of hippocampal-
dependent short-term memory are sensitive to chronic cannabinoid administration but other cognitive impairments are
temporary and probably result from a residue of cannabinoids in the brain or acute withdrawal effects from cannabinoids.
Understanding the effects of cannabinoids on cognitive function may provide us with tools to overcome these impairments
and for cannabinoids to be more favorably considered for clinical use.
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Introduction
Cannabis is the most widely used illicit drug after nicotine and
alcohol [1] and can impair several aspects of cognitive function
[2,3].
In humans, cannabinoids impair both encoding and recall of
verbal and non verbal information depending on dose and task
difficulty [2]. In animal studies, cannabinoids impair memory in a
variety of experimental conditions such as the radial maze,
instrumental discrimination tasks and the Morris water maze [4].
Given the well established role of the hippocampus in learning
and memory processes, and its high expression of CB1 receptors
[5,6], it is likely that the adverse effects of cannabinoids on spatial
learning tasks, short-term memory, and attention are attributable
to their actions within this brain region. Using electrophysiological
recordings from hippocampal slices, previous studies have shown
that cannabinoid receptor activation inhibits LTP in the
hippocampus [7–11]. We have shown that acute administration
of the CB1/2 receptor agonist WIN55,212-2 (WIN; 0.5 mg/kg)
impairs the induction of LTP in the schaffer collateral-CA1
projection of anesthetized rats [12]. Additionally, WIN adminis-
tered systemically or into the CA1 (5 mg/side) impairs spatial
learning in the water maze [12]. Hence, acute exposure to
cannabinoids impairs both hippocampal spatial learning and LTP.
Recently, we found that acute WIN administered into the ventral
subiculum (vSub; 5 mg/side) also impairs acquisition and retrieval
of memory in the social discrimination task [13].
A controversial question is whether long-term exposure to
cannabinoids can cause irreversible deficits in higher brain
function that persist after drug use stops. Cognitive deficits caused
by long term exposure to cannabinoids can last for many days, and
possibly for weeks [14–16], after discontinuing use, but it is still
unclear whether long-term cannabinoids exposure causes irrevers-
ible cognitive deficits.
Results from studies in humans [1] and rats [17,18] suggest that
vulnerableperiodsexistduring human and ratbrain development up
to the age of 16 years (post-natal day (PND) ,35–40 in rats), during
which cannabis can permanently compromise cognitive functions.
It is difficult to define the time course of adolescence, with no
single event signaling its onset or termination [19]. During
adolescence, the brain undergoes numerous changes [20]; massive
loss of synapses in neocortical regions, remodeling of the prefrontal
cortex, maturational changes in the hippocampus [20–22].
Neuroplastic modifications also include changes in dendritic spine
density, synaptic rearrangements and development of myelination
[23]. This remodeling process may be disrupted by cannabinoids
leading to lasting adverse effects on brain and behavior [23].
Receptors for endogenous cannabinoids mature slowly during the
postnatal period [24,25], with binding peaking during adolescence
at higher than adult levels in hippocampus [25]. These
endogenous cannabinoid systems may reach functional maturity
around adolescence [26,27].
Evidence from both animal and human studies suggests that
frequent exposure to cannabis during adolescence may have long-term
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[14,15,28,29,30]. However, studies on adults were not straightforward
in determining whether such deficits,o b s e r v e da f t e ro n l yh o u r so rd a y s
of abstinence, are temporary (perhaps due to a residue of cannabinoids
in the brain) or long-lasting (due to a neurotoxic effect of long-term
exposure). For example, Quinn et al., [23] found deficits in object
recognition following repeated exposure to D
9-THC (THC) in
adolescent but not adult rats, a result consistent with other reports of
cannabinoid administration in immature but not mature rats causing
lasting impairments in learning [17,18,28].
In the current study, we aimed to examine the short- and long-
term effects of chronic exposure to cannabinoids in the late-
adolescence period that falls between adolescence and adulthood
(PND ,45–60). To that end, male rats were chronically injected
with a cannabinoid receptor agonist during late-adolescence and
behavioral and electrophysiological measures of cognitive perfor-
mance were tested 24 hours, 10 and 30 days after cessation of drug
treatment.
Materials and Methods
Subjects
Male Sprague-Dawley rats (45 days old, ,200 g; Harlan,
Jerusalem, Israel) were caged together (5 per cage) at 2262uC
under 12-hour light/dark cycles (lights turned on at 07:00 and
turned off at 19:00). Rats had access to water and laboratory
rodent chow ad libitum. The experiments were approved by the
University of Haifa Ethics and Animal Care Committee, and
adequate measures were taken to minimize pain or discomfort.
Drug Treatment
The CB1/2-receptor agonist WIN55,212-2 (Tocris, USA) was
initially dissolved in dimethylsulfoxide (DMSO), and further
diluted with 1% Tween 80 and 98% saline (0.9% NaCl). Final
DMSO concentration was 1%. This DMSO and saline solution
was also used as the vehicle.
WIN was administered intraperitoneally (i.p.) at a dose of
1.2 mg/kg, 0.3 ml (based on previous reports [31,32]). For chronic
experiments, WIN was administered during PND 45–60, as the
rats received 14 injections i.p., one per day. For acute experiments,
WIN was administered in a single i.p. injection (1.2 mg/kg) 24 h
before testing.
The Morris Water Maze Task
The water maze, placed in a dimly lit room, consisted of a pool
of water (diameter 1.7 m; 50 cm high rim; manufactured by the
University of Haifa). For the spatial training task a submerged
escape platform (12612 cm) was placed 30 cm away from the
edge in a fixed location. Each trial was initiated by placing the
animal in one of three quadrants (in which there is no platform)
near the wall of the tank. Animals were allowed to search for the
hidden platform for a maximum of 60 s, while their latency to find
the hidden platform was manually recorded by an experimenter. If
a rat did not reach the platform within 60 s, an experimenter
would guide it there [12]. The rat was then allowed to remain on
the platform for 25 s before removal back to the home cage.
The experiment consisted of 3 days (Figure 1a). All trials are
presented in blocks of two. On the first day, the animals went
through a massed training protocol of 14 trials with inter-trial
intervals of 3 min [Acq1–7] [33], and 6 more trials to assess short-
term memory conducted after 30 min [STM1–3]. On the second
day, the animals underwent 8 trials to further train them before
assessing their performance in a reversal task, as the massed
protocol is considered to be less efficient in producing learning
than the spaced paradigms often used in other studies [33]
[LTM1–4]. This training session can also be a measure of long-
term memory retrieval as rats that have acquired the task will
demonstrate better performance. On the third day, the platform
was moved to the opposite quadrant of the maze. The animals
went through 10 reversal trials in which they were tested for their
ability to learn the new platform location [R1–R5].
Object location memory task
This task measures an animal’s ability to detect that an object
has moved to a new location. This is a hippocampal-dependent
spatial memory task [34–36]. The objects were two small identical
ceramic dolls (106867 cm; painted blue and pink) located in a
squared black open-field (50650650 cm) under dim light, 10 cm
from the walls. The open-field and the objects were thoroughly
cleaned between trials with odorous clean wipes.
The rats were habituated to the experimental apparatus by
allowing them to explore it for 10 min every day for 4 days
without objects before the experiment was performed. In the
sample phase, each rat was placed in the open-field arena and
exposed to the objects for 5 min. The test phase was given 30 min
after the sample trial (i.e., to test short-term memory). One object
was moved to a new location and the time spent exploring the
objects at the old and new locations were recorded for 5 min.
A digital camera placed above the arena and connected to a
video tape was used to track rat behavior during the exploration
session. Recorded data was analyzed by two judges blind to
experimental conditions and inter-rater reliability was assured.
Exploration was defined as when the subject sniffed at, whisked
at, or looked at the object from no more than 2 cm away. An
exploration index calculated for each animal was expressed as TN/
(TN+TF)( TF=time spent exploring the object in the familiar
location; TN=time spent exploring the object in the novel
location). Intact spatial recognition memory in the test phase
was reflected in an exploration score higher than 0.5, which
implies greater exploration of the object in the novel location
(Figure 2a).
Object recognition memory task
This task measures the ability to discriminate the familiarity of
previously encountered objects. If a rat is presented with both a
familiar object and a novel object, it will direct more exploration at
the novel object. This task is dependent on the prefrontal cortex
and perirhinal cortex [37,38]. In the sample phase, each rat was
placed in the open-field arena and exposed to two identical objects
(the same objects as in the object location memory task) for 5 min.
In the test phase, thirty min after the sample trial, the rat was
presented with one of the objects from the sample trial and with a
novel object (ceramic triangle, 10.56562 cm; painted gray) for
5 min (Figure 1c). The familiar and novel objects were
counterbalanced during the sample and test phases. The rest of
the parameters were identical to the object location task described
above.
Electrophysiology
Surgical Procedure. Rats were anesthetized (with 40%
urethane, 5% chloral hydrate in saline, injection volume of
4 ml/1 kg, i.p.) and placed in a stereotaxic frame. Small burr holes
were drilled in the skull to allow electrodes to be inserted into the
brain. A recording microelectrode (glass, tip diameter of 2–5 mm,
filled with 2 M NaCl, resistance of 1–4 M) was inserted into the
DG (anteroposterior, 24.0 mm; lateral, 62.5 mm; ventral,
23.7 mm) (Figure 2a) or into the NAc shell (anteroposterior,
+1.6 mm; lateral, 61.0 mm; ventral, 25.5 mm) (Figure 2b). A
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PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31731Figure 1. The effects of chronic exposure to WIN55,212-2 during late-adolescence on hippocampal and non-hippocampal
dependent tasks. 1a. Rats tested in the water maze 24 h, but not 10 d, after the last WIN injection, show increased latency to locate the hidden
platform compared with the vehicle group on the first training day (Acq1–7). (*, p,0.05: WIN 24 h different from Vehicle 24 h). Inset: a control
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perforant path (PP; anteroposterior, 28.0 mm; lateral, 64.0 mm;
ventral, 23.0 mm) (Figure 2a) or the vSub (anteroposterior,
26.5 mm; lateral, 65.0 mm; ventral, 26.0 mm), respectively
(Figure 2b). After positioning the electrodes, the rat was left for
60 minutes before commencing the experiment.
LTP Induction. LTP was induced by theta-like high-
frequency stimulation (HFS) (three sets of 10 trains; each train
consisting of 10 pulses at 200 Hz; inter-train interval, 200 ms;
inter-set interval, 1 min) to the vSub or PP. Field potentials were
recorded from the NAc or DG every 5 minutes for 60 minutes
after HFS to the vSub/PP. LTP was measured as an increase in
the amplitude of the excitatory post-synaptic potentials (EPSPs).
Potentiation was measured as a percentage change from the
average of the 30 min baseline before HFS.
Open Field
The apparatus consisted of a square black open-field
(50650650 cm). The floor was divided by 1-cm-wide white lines
into 25 squares measuring 10610 cm each. A video image of the
open-field was displayed on a TV monitor, and the movements of
the rat were manually recorded by two ‘blind’ experimenters and
analyzed in order to measure motor activity over a period of
5 min.
Recordings were made of the time the rat spent in the central
and peripheral squares, the number of instances of rearing, and
the total distance covered (Figure 3). The open-field arena was
thoroughly cleaned between trials with odorous clean wipes.
Sucrose intake
Water bottles were removed before the dark part of the cycle,
and replaced with bottles containing a 1% sucrose solution.
Sucrose consumption was measured during the 12 dark hours of
the cycle and was then normalized according to every rat’s specific
weight (Figure 4a). Rats were individually housed during the
sucrose intake measurement.
Statistical Analysis
The results are expressed as means 6SEM. For statistical
analysis, mixed design ANOVA, 3-way mixed ANOVA, 2-way
ANOVA, and t-test were used as indicated. All post hoc
comparisons were made using the least significant difference
multiple-comparison test (LSD).
Experimental design
Rats were chronically injected for 14 days with WIN or vehicle.
Every rat underwent one behavioral or electrophysiological test, to
prevent carryover effects due to multiple tests. However, the
sucrose consumption and weight gain measures were taken from
rats that were tested behaviorally or electrophysiologically. Hence,
different groups of rats were tested at the different time points post-
injection.
Behavioral measures: (i) water maze– 24 h or 10 days after
the last chronic injection and 24 h after a single injection
(figure 1a), (ii) object location task– 24 h, 10, 30 or 75 days after
the last chronic injection and 24 h after a single injection
(figure 1b), (iii) object recognition task– 24 h, 10 days or 30 days
after the last chronic injection and 24 h after a single injection
(figure 1c).
Electrophysiological measures: (i) LTP in the PP-DG
pathway– 24 h, 10 days or 30 days after the last injection
(figure 2a), (ii) LTP in the vSub-NAc pathway– 24 h, 10 days or 30
days after the last chronic injection and 24 h after a single
injection (figure 2b).
Control experiments: (i) locomotion and anxiety-like
behavior in the open field– 24 h, 10 days or 30 days after the
last injection (figure 3), (ii) sucrose consumption– 24 h, 10 days or
30 days after the last injection (figure 4a), and (iii) weights– 24 h,
10 days or 30 days after the last injection (figure 4b).
Results
The effects of chronic exposure to the cannabinoid
receptor agonist WIN55,212-2 during late adolescence
on hippocampal and non-hippocampal dependent tasks
To determine the effects of chronic exposure to WIN during
late-adolescence on spatial learning and memory, we used two
hippocampal- dependent paradigms: the aversive Morris water
maze task, and the non-aversive object location task.
The Morris water maze. Rats were injected with vehicle or
WIN for 2 weeks and after 24 h (Vehicle 24 h, n=8; WIN 24 h,
n=7) or 10 days (Vehicle 10 d, n=8; WIN 10 d, n=7) taken to
the water maze. The data were analyzed using a 3-way mixed
ANOVA with treatment (Vehicle/WIN) and time of testing (24 h,
10 d) as between-subject factors, and the trials of training (Acq,
STM, LTM, R) as a within-subject factor (Figure 1a).
On day one, analysis of the acquisition data [Acq1–7] revealed
significant main effects for treatment (F(1,26)=4.03, p=0.05),
for time of testing (F(1,26)=5.31, p,0.05), and for trials
(F(1,26)=112.29, p,0.001). Significant interactions were found
for [trials6treatment] (F(1,26)=14.21, p=0.01), for [trials6time of
testing] (F(1,26)=12.69, p=0.01), and for [trials6treatment6time
of testing] (F(1,26)=14.43, p=0.01). Post-hoc analysis revealed a
significant difference in latency to find the hidden platform
between the vehicle treated rats and the WIN treated rats after
24 h (p,0.05), indicating that 24 h after the last chronic injection
the WIN treated rats took longer to find the hidden platform than
the vehicle treated rats (Figure 1a).
Thirty min after training rats were tested in the maze for their
short-term memory of the platform location (STM1–3). A
significant main effect for time of testing (F(1,26)=12.3, p,0.01)
was found. There was no significant main effect for treatment
(F(1,26),1, NS), and no significant interaction effect (F(1,26),1, NS).
On day two, 48 hours after the last chronic injection, rats were
tested in the maze for their long-term memory of the platform
location (LTM1–4). A significant main effect for time of testing
(F(1,26)=4.29, p,0.05) and for trials (F(1,26)=9.8, p,0.01) was
found. There was no significant main effect for treatment
(F(1,26),1, NS), and no significant interaction effect (F(1,26),1,
NS). The absence of a significant difference between the treatment
groups indicates that on day two there were no treatment effects
on performance.
experiment where rats were tested in the water maze 24 hours following a single WIN injection. 1b. Rats tested in the object location task 24 h, 10 d,
30 d and 75 d after the last vehicle injection spent significantly more time exploring the new location compared with the WIN groups. (*, p,0.05;
**, p,0.01: Vehicle different from WIN). On the right square: a control experiment where rats were tested in the object location task 24 hours
following a single WIN injection. 1c. Rats tested in the object recognition task 24 h or 10 d, but not 30 d, after the last vehicle injection spent
significantly more time exploring the new location compared with the WIN groups (*, p,0.05; ***, p,0.001: Vehicle different from WIN). On the
right square: a control experiment where rats were tested in the object recognition task 24 hours following a single WIN injection.
doi:10.1371/journal.pone.0031731.g001
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platform was moved to the opposite quadrant of the maze and the
rats were trained to find this new location. A significant main effect
for trials (F(1,26)=128.47, p,0.001) was found. There was no
significant main effect for treatment (F(1,26),1, NS), for time of
testing (F(1,26)=2.37, NS), and no significant interaction effect
(F(1,26),1, NS).
In order to find whether the pattern of acquisition on the water
maze task in the WIN treated rats 24 hours after chronic
treatment is the result of an acute effect on learning, we conducted
a control experiment where we treated rats with an acute dose of
WIN (1.2 mg/kg) and then tested their acquisition of the water
maze task after 24 h (Vehicle, n=7; Acute WIN24h, n=7;
Figure 1a, inset). Mixed design ANOVA [treatment6trials
(267)] of the acquisition data [Acq1–7] revealed a significant effect
for trials (F(1,12)=66.74, p,0.001), indicating the rats’ improve-
ment over trials in finding the hidden platform. There were no
significant effects for treatment (F(1,12),1, NS), or a significant
Figure 2. The effects of chronic exposure to WIN55,212-2 during late-adolescence on synaptic-plasticity in the hippocampus and
nucleus-accumbens. 2a. Chronic administration of WIN had no effect on LTP levels in the PP-DG pathway measured 24 h, 10 d or 30 d after the
last drug injection. Inset: Up: representative traces in the DG for the vehicle group taken before (black) and 5 min after (gray) HFS to the PP
(calibration: 0.2 mV, 10 ms); Down: schematic drawing of electrodes tip positions: left - representative location of the stimulating electrode tip in the
perforant path (anteroposterior, 28.0 mm; lateral, 64.0 mm; ventral, 23.0 mm), right - representative location of the recording electrode tip in the
dentate gyrus (anteroposterior, 24.0 mm; lateral, 62.5 mm; ventral, 23.7 mm). 2b. Chronic administration of WIN impaired LTP levels in the vSub-
NAc pathway measured 24 h or 10 d, but not 30 d, after the last drug injection. (**, p,0.01: WIN 24 h group different from WIN 30 d and Vehicle
groups, and WIN 10 d group different from WIN 30 d group; ***, p,0.001: WIN 10 d group different from Vehicle group). Inset: Up: representative
traces in the NAc for the vehicle group taken before (black) and 5 min after (gray) HFS to the vSub (calibration: 0.2 mV, 10 ms); Down: schematic
drawing of electrodes tip positions: left - representative location of the stimulating electrode tip in the ventral subiculum (anteroposterior, 26.5 mm;
lateral, 65.0 mm; ventral, 26.0 mm), right - representative location of the recording electrode tip in the nucleus accumbens (anteroposterior,
+1.6 mm; lateral, 61.0 mm; ventral, 25.5 mm); On the right: a control experiment where acute administration of WIN impaired LTP levels in the
vSub-NAc pathway measured 24 h after a single injection (**, p,0.01).
doi:10.1371/journal.pone.0031731.g002
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This suggests that an acute single injection of WIN does not affect
the performance in the water maze task 24 h after the injection.
The object location task. Next, we examined the effects of
chronic exposure to WIN during late-adolescence on short term
spatial memory in the non-aversive object location task. The data
were analyzed using a 2-way ANOVA with treatment (Vehicle/
WIN) and time of testing (24 h, 10 d, 30 d, 75 d) as independent
variables, and exploration index as a dependent variable. A
significant main effect was found for treatment (F(1,55)=21.35,
p,0.001), suggesting that in all time points measured, the WIN
treated rats spent significantly less time exploring the novel
location compared with the vehicle treated rats (Figure 1b).
There was no significant main effect for time of testing (F(3,55),1,
NS), or a significant interaction effect (F(3,55),1, NS).
One-sample t-test performed on each of the vehicle and WIN
groups revealed a significant difference from the 50% exploration
index point at all times tested in the Vehicle group [24 h:
(t(5)=4.26, p,0.01); 10 d: (t(8)=2.82, p,0.05); 30 d: (t(9)=3.88,
p,0.01); 75 d: (t(6)=2.97, p,0.05)], but not in the WIN group.
Thus, 24 hours, 10, 30 and 75 days after withdrawal, rats still
demonstrate impaired short-term memory in the object location
task.
There was no significant difference in the sample phase (day 1)
between any of the groups in exploration index (mean6SD)
24 h (Vehicle: 45.7662.19; WIN: 51.361.84), 10 d (Vehicle:
52.0764.01; WIN: 52.5862.51), 30 d (Vehicle: 53.3963.34;
WIN: 52.8662.11), or 75 d (Vehicle: 50.6862.36; WIN:
51.6961.42) after withdrawal.
In order to find whether the effects seen on spatial memory after
24 hours of withdrawal would also be evident after a single
injection of WIN, we performed a control experiment, in which we
examined the effects of an acute administration of WIN (1.2 mg/
kg) on spatial short term memory in the object location task. We
tested the rats in the object location task 24 hours after a single
injection. Independent-samples t-test did not reveal a significant
difference between the groups (Vehicle: 65.762.75; WIN:
68.7662.53; t(10),1, NS), indicating that an acute single injection
of WIN does not affect the performance in the object location task
24 h after the injection (figure 1b, right square).
In a separate experiment we aimed to test whether a lower dose
of chronic WIN (0.5 mg/kg instead of 1.2 mg/kg) is enough to
impair performance in the object location task. As we were
interested in long-term effects, rats were tested in this task after 10
days of withdrawal (Vehicle, n=7; WIN 10 d, n=9). Indepen-
dent-samples t-test revealed that rats treated with a lower dose of
WIN also exhibited impairment in short-term memory
(mean6SD) (45.3465.11) compared with vehicle treated rats
(60.6764.64), 10 days after the last injection (t(14)=2.16, p,0.05),
suggesting that chronic treatment with a lower dose of WIN may
be sufficient for the observed short term memory impairment.
The object recognition task. Since chronic exposure to
WIN during late-adolescence affected non-aversive short-term
hippocampal dependent spatial memory, we asked whether these
effects will appear in a similar non-hippocampal dependent task.
To that end we used the object-recognition task, which examines
the visual and tactile properties of the explored objects rather than
their spatial location.
The data were analyzed using a 2-way ANOVA with treatment
(Vehicle/WIN) and time of testing (24 h, 10 d, 30 d) as
independent variables and exploration index as a dependent
variable (Figure 1c). A significant main effect was found for
treatment (F(1,50)=15.17, p,0.001), and a significant interaction
effect of [treatment6time of testing] (F(2,50)=3.23, p,0.05). There
was no significant main effect for time of testing (F(2,50)=1.38, NS).
Independent samples t-test revealed that the main effect of
treatment stemmed from the fact that the WIN treated rats spent
Figure 3. The effects of chronic exposure to WIN55,212-2
during late-adolescence on locomotion and anxiety in the
open-field. 3a. Chronic administration of WIN caused an increase in
the time the rats spent in the center when tested in the open field 24 h
after the last drug injection. (*, p,0.05: Vehicle different from WIN). 3b.
Chronic administration of WIN had no effect on the number of rearings
the rats performed in the open field when measured 24 h, 10 d or 30 d
after the last drug injection. 3c. Chronic administration of WIN had no
effect on the distance the rats covered in the open field when
measured 24 h, 10 d or 30 d after the last drug injection.
doi:10.1371/journal.pone.0031731.g003
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the vehicle treated rats, after 24 hrs (t(18)=3.76, p=0.001) and
10 d (t(10.34)=2.38, p,0.05) of withdrawal.
One-sample t-test performed on each of the vehicle and WIN
groups revealed a significant difference between the Vehicle group
and the 50% exploration index point at all times tested, [24 h:
(t(9)=6.92; p,0.001), 10 d: (t(7)=10.09; p,0.001), 30 d:
(t(9)=4.89; p=0.001)], and in the WIN group a significant
difference was found at 10 d (t(7)=2.41, p,0.05) and 30 d:
(t(9)=6.55, p,0.001).
In order to find whether the effects seen in the object
recognition task after 24 hours of withdrawal would also be
evident after a single injection of WIN, we conducted a control
experiment, in which we examined the effects of an acute
administration of WIN (1.2 mg/kg) on short term object recognition
memory. Independent-samples t-test did not reveal a significant
difference between the groups (Vehicle: 63.5164.16; WIN:
60.1363.47; t(11),1, NS), indicating that an acute single injection
of WIN does not affect the performance in the object recognition
task 24 h after the injection (figure 1c, right square).
The effects of chronic exposure to the cannabinoid
receptor agonist WIN55,212-2 during late adolescence
on synaptic plasticity
Synaptic plasticity in the perforant path-dentate gyrus
pathway. Next we sought to examine whether chronic WIN
administration would impair hippocampal LTP. Rats were
anesthetized and taken for electrophysiological recording in the
PP-DG pathway 24 h, 10 d or 30 d after the last chronic WIN
Figure 4. The effects of chronic exposure to WIN55,212-2 during late adolescence on sucrose consumption. 4a. Chronic administration
of WIN had no effect on sucrose consumption when measured at baseline, 24 h, 10 d or 30 d after the last drug injection. 4b. Chronic administration
of WIN had no effect on weight gain compared to the vehicle group when measured at baseline, 24 h, 10 d, or 30 d after the last drug injection.
doi:10.1371/journal.pone.0031731.g004
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difference in EPSP amplitude following HFS between vehicle
injected rats tested 24 h (n=4), 10 days (n=4) or 30 days (n=4)
after the last injection (F(2,9)=1.2, NS), and hence the vehicle
group was grouped to one for reasons of clarity.
Mixed design ANOVA [treatment6time (4613)] post-HFS did
not indicate a significant effect on EPSP amplitude for the
treatment (F(3,26),1, NS), or the interaction between treatment
and time (F(3,26)=1.39, NS; Figure 2a). There was a significant
within-subject effect for the time (F(1,26)=63.48, p,0.001), due to
a decrease in potentiation levels from the post tetanic potentiation
(measured 1 min after HFS) throughout the experiment in all
groups. Hence, chronic exposure to WIN did not have a
significant effect on the induction of LTP in the PP-DG pathway
at any of the time points examined. Mixed design ANOVA on
EPSP amplitude pre-HFS [treatment6time (466)] did not reveal
significant effects for the treatment (F(3,26)=1.22, NS), the time
(F(1,26)=2.35, NS), or the interaction between treatment and time
(F(3,26)=2.72, NS).
Synaptic plasticity in the ventral subiculum-nucleus
accumbens pathway. Rats were anesthetized and taken for
electrophysiological recording in the vSub-NAc 24 h, 10 d or 30 d
after the last WIN injection and compared to a vehicle group. We
found no difference between vehicle injected rats tested 24 h, 10 d
or 30 d after the last injection, and hence the vehicle group was
grouped to one for reasons of clarity (n=8).
Mixed design ANOVA [treatment6time (4613)] post-HFS
indicated significant effects on EPSP amplitude for the treatment
(F(3,28)=6.91, p=0.001), for the time (F(1,28)=4.18, p=0.05), but
not for the interaction between treatment and time (F(3,28),1, NS;
Figure 2b). Post hoc analysis revealed significantly higher levels of
potentiationinthevehiclegroupandtheWIN30 dgroupcompared
with the WIN 24 h group (p,0.01, different from Vehicle; p,0.05,
different from WIN 30 d) and with the WIN 10 d group (p,0.001,
different from Vehicle; p,0.01, different from WIN 30 d). Hence,
chronic exposure to WIN impaired the induction of LTP in the
vSub-NAc pathway 24 h and 10 d, but not 30 d after withdrawal.
Mixed design ANOVA on EPSP amplitude pre-HFS [treatment6
time (466)] did not reveal significant effects for the treatment
(F(3,28),1, NS), or the time (F(1,28),1, NS), or the interaction
between treatment and time (F(3,28)=1.85, NS).
In order to find whether the impairment of LTP seen after 24 h
and 10 d would appear also following a single injection of WIN, rats
were treated with an acute dose of WIN (1.2 mg/kg) and then taken
for electrophysiological recording in the vSub-NAc after 24 h
(Vehicle, n=5; Acute WIN24h, n=5; Figure 2b, inset on the
right side). Mixed design ANOVA [treatment6time (2613)]
indicated significant effects on EPSP amplitude for the treatment
(F(1,8)=17.51,p,0.01), for thetime(F(1,8)=8.9,p,0.05), but not for
the interaction between treatment and time (F(1,8),1, NS). This
suggeststhat an acute singleinjectionofWINaffectsLTPinthe NAc
24 h after the injection. Mixed design ANOVA on EPSP amplitude
pre-HFS[treatment6time (266)]did not revealsignificant effectsfor
the treatment (F(1,8),1, NS), or the time (F(1,8),1, NS), or the
interaction between treatment and time (F(1,8),1, NS).
The effects of chronic exposure to the cannabinoid
receptor agonist WIN55,212-2 during late adolescence
on the rats’ weight, sucrose consumption and
performance in an open field test
To exclude motor deficits or other non-specific alterations that
might have caused the effects on learning and plasticity, rats were
chronically administered with WIN and tested for locomotion and
anxiety levels in the open field and their weights and sucrose
consumption were monitored.
Open field. The data were analyzed using a 2-way ANOVA
with treatment (Vehicle/WIN) and time of testing (24 h, 10 d,
30 d) as independent variables, and time in the center/number of
rearings/distance covered as dependent variables.
Analysis of the time the rats spent in the center of the open field
revealed a significant main effect for time of testing (F(2,47)=5.39,
p,0.01), a significant effect for treatment (F(1,47)=5.6, p,0.05),
and a significant interaction effect (F(2,47)=3.85, p,0.05). Post-
hoc comparisons revealed that the significant main effect of time of
testing stemmed from a significant difference between the 24 h
groups and the 10 d groups (p,0.01), and between the 24 h group
and the 30 d group (p,0.01).
Independent-samples t-test revealed a significant difference
between the treatment groups 24 h after withdrawal (t(12.83),1,
p=0.01), suggesting that the WIN group (n=10) spent signif-
icantly more time in the center of the open field than the vehicle
group (n=10), perhaps indicating their lower level of stress
compared to the vehicle group (Figure 3a). There were no
significant differences between the treatment groups after 10 days
of withdrawal (t(17),1, NS), or after 30 days of withdrawal
(t(8.8),1, NS).
Analysis of the number of rearings the rats performed in the
open field revealed a significant main effect for time of testing
(F(2,47)=20.78, p,0.001; Figure 3b). Post-hoc comparisons
revealed that this effect stems from significant differences between
the 24 h groups (mean6SD) (WIN: 35.862.94; Vehicle:
32.462.94) and the 10 d groups (WIN: 16.5663.1; Vehicle:
18.662.94; p,0.001), and between the 24 h group and the 30 d
group (WIN: 12.5763.5; Vehicle: 20.4363.52; p,0.001).
Analysis of the distance the rats covered in the open field
revealed a marginally significant main effect for treatment
(F(1,46)=3.96, p=0.053). However, independent-samples t-test
did not reveal a significant difference between the treatment
groups at any of the time points tested (24 h: t(18),1, NS; 10 d:
t(16),1, NS; 30 d: t(12),1, NS), suggesting no effect on gross
motoric behavior (Figure 3c). This could indicate a possible
tolerance effect to the chronic administration of WIN.
Sucrose consumption test. To examine the effects of
chronic exposure to WIN during late-adolescence on hedonia,
we used the sucrose consumption test. We measured sucrose intake
before injection (baseline), 24 h, 10 d, and 30 d after the last
injection (Figure 4a).
Two-way ANOVA with treatment (Vehicle/WIN) and time of
testing (baseline, 24 h, 10 d, 30 d) as independent variables, and
sucrose consumption as the dependent variable did not reveal
significant effects for the treatment (F(1,13),1, NS), or the
interaction between treatment and time of testing (F(1,13),1,
NS). There was a significant main effect for time of testing
(F(1,13)=9.51, p,0.01).
Weight. We also measured the rats’ weight up to 30 days after
the last injection. Rats were weighed before injection (baseline),
24 hrs, 10 days, or 30 d after the last injection (Figure 4b). Mixed
design ANOVA on weight gain [treatment6time point (264)] did
not reveal significant effects for the treatment (F(1,11)=3.11, NS), or
theinteractionbetweentreatmentandtimepoint(F(1,11),1,NS),but
there was a significant within-subject effect for the time point
(F(1,11)=660.98, p,0.001), signifying the rats’ weight gain over time.
Discussion
Our findings suggest that the effects of chronic cannabinoid
exposure in the late-adolescent period in rats on learning and
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most robust effect of chronic WIN administration was the
impairment of short-term memory in the spatial version of the
object recognition task that persisted even after 75 days of
withdrawal. However, we found a gradual recovery of behavioral
and electrophysiological impairments in acquisition and short-
term memory in the water maze, short-term object recognition
memory, and LTP in the vSub-NAc pathway. No significant long-
term effects of chronic WIN were observed on locomotion, sucrose
consumption or weight gain. Hence, most of the deficits observed
were temporary corroborating with previous studies showing that
long-term cannabinoid administration produces CB1 receptor
desensitization and down-regulation in the hippocampus that
recovers to control level at 14 days after cessation of treatment
[39,40].
The effects of chronic exposure to WIN55,212-2 during
late adolescence on performance in behavioral tasks
The acquisition in the spatial task in the Morris water maze was
impaired after 24 hrs of withdrawal corroborating with previous
studies using THC and HU-210 [41,42]. The impairment was no
longer evident after 10 days of withdrawal, suggesting that the
24 hrs effect could be due to drug residue of cannabinoids in the
CNS or to withdrawal effects from the drug. This is consistent with
Wise et al. [43], showing that the induction of withdrawal in
THC-dependent rats impaired performance in the water maze.
Twenty-four hours after withdrawal, both treatment groups
showed poor short-term spatial memory, perhaps due to the less
efficient training in the massed protocol compared with the spaced
protocol used in other studies [33]. Acute treatment with WIN did
not affect the acquisition of the water maze task, excluding the
possibility that an acute single injection of WIN affects spatial
learning 24 h after the injection.
In the spatial version of the object recognition task, WIN-
treated rats showed impairment in short-term memory that was
evident up to 75 days after the last injection. This is a robust effect
suggesting that this type of spatial memory is more sensitive to the
effects of chronic WIN exposure during late adolescence than the
water maze task. The first explanation for the differential effects of
WIN on performance involves the different level of stress in each
task. The water maze is a highly aversive learning task, especially
when using the massed training protocol [33] whereas the object
location task is considered non-aversive. The cannabinoid system
and the stress system are highly interconnected [44–49] and it may
be that the effects of WIN on performance in a stressful learning
paradigm are different than in a neutral task. Several studies
suggested that the cannabinoid system is not involved in the
extinction of non-aversive memories [50–52]. Harloe et al. [50]
examined extinction learning under aversive and appetitive
conditions, and reported impairment of extinction learning by a
cannabinoid antagonist only under aversive conditions, suggesting
that the endocannabinoid system might become activated
specifically in highly aversive situations. Similarly, we have
recently shown that WIN microinjected into the basolateral
amygdala can prevent the effects of stress exposure (elevated
platform stress) on performance in an aversive learning task (i.e.,
conditioned avoidance and extinction of inhibitory avoidance)
[53], but WIN could not prevent the effects of the same stressor on
the performance in the non-aversive object location task [54].
Hence, a possible interaction between WIN and the stressfulness of
the task may have a different outcome on performance. The
second explanation relates to the brain areas involved in these
tasks. The water maze task heavily relies on the dorsal CA1 area
[55–57], and the object location task, although heavily relying on
the hippocampus, also involves other brain areas (i.e., prefrontal
cortex, perirhinal cortex; [58–61,38]) that are also affected by the
chronic systemic administration of WIN. As in the water maze
task, chronic treatment with WIN was necessary in order to cause
impairment in performance, since no impairment was evident
24 hours after a single WIN injection.
In the non-spatial object recognition task, we found a gradual
recovery over time of short-term memory impairment, perhaps due
to drug residue. At 10 days after withdrawal, the WIN treated rats
demonstrated attenuated performance compared to the vehicle
treated rats, however their exploration index was significantly
higher than chance levels, suggesting that they acquired the task.
After 30 days of withdrawal, when the drug components would
reasonably be expected to have disappeared from the CNS [62,63],
no effect on short-term memory could be discerned. The object
recognition task is to a great extent dependent on the prefrontal
cortex and the perirhinal cortex [37,38], which may suggest a
greater sensitivity of the hippocampus than the cortex to the effects
of chronic WIN treatment during late-adolescence. An acute single
injection of WIN did not affect performance in the object
recognition task 24 h after the injection suggesting that chronic
treatment with WIN is required for memory impairment to occur.
Table 1. Summary of results.
Time Point
Test 24 hours 10 days 30 days
Water maze Impairment in acquisition No effect -
Location recognition Impairment in short-term memory Impairment in short-term memory Impairment in short-term memory
(also at 75 days)
Object recognition Impairment in short-term memory Attenuation of short-term memory No effect
Synaptic plasticity – PP-DG No effect No effect No effect
Synaptic plasticity – vSub-NAc Impairment of LTP Impairment of LTP No effect
Open field Increased time in the center No effect No effect
Sucrose consumption No effect No effect No effect
Weight No effect No effect No effect
The table summarizes the effects of chronic i.p. treatment with the CB1/CB2 receptor agonist WIN55,212-2 (1.2 mg/kg) for two weeks during the late adolescence
period (post-natal days 45–60) on behavioral and electrophysiological measures of cognitive performance tested 24 hrs, 10 and 30 days after the last drug injection.
doi:10.1371/journal.pone.0031731.t001
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late adolescence on synaptic plasticity
Chronic WIN administration during late adolescence had no
significant effect on plasticity in the DG hippocampal area
although there are very high levels of CB1 receptors in all
subfields of the hippocampus, including the DG [64–66]. A
possible explanation for the lack of effect is low sensitivity or
adaptation of DG neurons to high chronic levels of WIN. Yet, a
recent study found that acute WIN affects miniature inhibitory
postsynaptic currents in the DG without altering event amplitude,
area, rise time, or decay [67]. This study showed that WIN
potentiated action potential-independent release of GABA in the
DG which was not mediated through a CB1or CB2 receptor
mechanism [67]. This may suggest that although WIN has no
effect on HFS-induced plasticity in the DG, it affects the
spontaneous release of GABA.
We have recently found that acute administration of WIN
(0.5 mg/kg) significantly impaired LTP in the schaffer collateral-
CA1 projection [12]. Here we found that chronic administration
of either vehicle or WIN impaired LTP in the schaffer collateral-
CA1 pathway (data not shown). Hence, we could not differen-
tiate, using our paradigm, between the effects of chronic WIN
exposure and the stress-induced effects of chronic i.p. injections
on LTP. Daily injections can constitute chronic stress for the rats,
and the CA1 area is highly sensitive to stress [68,69]. Hill et al.
[70] found that rats that were chronically exposed to high levels
of the CB1 receptor agonist HU-210 demonstrate impaired LTP
in the CA1 region when examined 18 h following the final drug
administration. There are several differences between our
experiment and Hill’s; drug administration began when the rats
were 300 g, the same point at which we end our drug
administration; electrophysiological recording and stimulating
electrodes were in different coordinates than in our chronic
experiment; rats injected with HU-210 were taken for electro-
physiology after completing extensive behavioral training.
In the vSub-NAc pathway chronic WIN impaired LTP induced
after 24 hrs or 10 days, but not after 30 days, of withdrawal. LTP
in this pathway is NMDA-dependent [71,72]. Also, it has been
suggested that the NAc, by integrating vSub input of contextual
information, mediates goal-directed behavior and that the
hippocampal input in the NAc is well placed to influence reward
and incentive systems [73,74]. The NAc represents a critical site
for mediating the rewarding and/or addictive properties of several
classes of abused drugs, including ethanol, opioids, psychomotor
stimulants, and marijuana [75–77].
Acute treatment with WIN impaired LTP after 24 hours in
this pathway. This could suggest that the NAc is particularly
sensitive to the effects of WIN due to its involvement in the
neural processing of rewarding stimuli. The role of the NAc in
behavior reinforced by both natural reward [78] and drugs of
abuse is supported by vast experimental evidence [79,80].
Moreover, in vivo experiments indicate that cannabinoids reduce
excitability of NAc neurons [81]. This acute effect is consistent
with Mato et al. [82] who found impairment of LTD in the NAc
and CA1, 24 hours following a single in vivo injection of THC.
This effect was reversible within 3 days, suggesting that the
modification in the functional properties of cannabinoid
receptors was transient. Together with our previous findings on
the impairing effects of acute WIN on LTP in the CA1 [12] the
data suggest that alterations in synaptic plasticity as a result of
cannabinoid treatment can occur within 24 hours of acute
exposure.
The effects of chronic exposure to WIN55,212-2 during
late adolescence on non memory related measures
Chronic exposure to WIN had no effect on weight gain, sucrose
consumption or gross locomotion, but it significantly affected the
rats’ level of anxiety, as measured in the open field, after 24 hrs of
withdrawal. These findings suggest that the long-term effects of
chronic WIN on learning and plasticity are probably not due to
changes in sensory-motor parameters or other non-specific effects.
Since acute administration of cannabinoids results in depression
of motoric activity in the open field, and chronic administration
results in tolerance to these effects [83], the lack of effect here on
locomotion could be the result of tolerance to WIN, developed
over the two weeks of daily injections.
Increased time spent in the central part of the open field arena is
an indication of a reduction in anxiety-like behavior [84].
Activation of the cannabinoid system has anxiolytic properties
[45,85] that could explain the effect in the open field 24 hrs after
withdrawal when drug residue may still be present in the CNS.
Anhedonia, or the decreased ability to experience pleasure, can
be examined in rats by reduction in sucrose intake. Responding to
natural and artificial rewards is mediated by the NAc and its
dopaminergic inputs [86]. Although we found that chronic WIN
interferes with LTP in the NAc, no effect was observed in sucrose
consumption. This may suggest a greater sensitivity of the LTP-
mediated neural circuit in the NAc to the effects of chronic WIN
than the neural circuit mediating sucrose intake.
Long-term effects of cannabinoids
Prolonged exposure to cannabinoid agonists in laboratory
animals is associated with the development of tolerance to most of
their pharmacological effects [87]. There is a brief ‘drug residue’
effect of 12–24 hrs after acute exposure to cannabinoids that may
persist longer in chronic users [63]. The average terminal
elimination half-life of the THC metabolite THCCOOH in plasma
ofchronic cannabis usersisas long as4.3daysand maybe aslongas
12.6 days [88]. WIN has a shorter half-life than THC [89–91] and
undergoes significant metabolism similar to that of other cannabi-
noids [92]. Prolonged treatment with THC or with WIN resulted in
cannabinoid receptor desensitization and down-regulation through-
out the brain, as well as tolerance to cannabinoid-mediated effects,
and attenuation of CB1 receptor-mediated G-protein activation
that persisted for several days after cessation of treatment [39–40].
In adolescent rats, this desensitization of CB1 receptors following
prolonged treatment with THC is slower than in adults, perhaps
contributing to the differentiation in long-lasting cognitive effects
between adolescents and adults [93].
Summary
Our results point to a gradual recovery over time rather than
persistent long-lasting impairments following chronic WIN
administration. Yet, WIN had a long-term impairing effect on
performance in a non-aversive hippocampal-dependent short-term
memory task, corroborating animal and human studies on short-
term memory [94–98].
Studying the lasting effects of cannabinoids on cognitive
function may advance our understanding of the potential harmful
consequences of cannabinoids. Dissociating the short-term from
the long-lasting effects of cannabinoids may indicate whether long-
term exposure to cannabinoids is associated with long-lasting
deficits in higher brain function that persist after drug use stops.
This will help in determining whether the clinical benefits of using
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deficits induced by cannabinoids.
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